SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-286608
Filing Date
2019-11-07
Accepted
2019-11-07 07:13:03
Documents
4
Period of Report
2019-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d824083d8k.htm 8-K 24503
2 EX-10.1 d824083dex101.htm EX-10.1 62454
3 EX-99.1 d824083dex991.htm EX-99.1 56567
4 GRAPHIC g824083g1106215426541.jpg GRAPHIC 4685
  Complete submission text file 0001193125-19-286608.txt   151499
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 191198116
SIC: 2834 Pharmaceutical Preparations